Propanc Health Group Corporation to Present at the 9th Annual LD Micro Main Event

LOS ANGELES, CA / ACCESSWIRE / November 30, 2016 / Propanc Health Group Corporation (PPCH) (“Propanc” or “the Company”), an emerging healthcare company focusing on development of new and proprietary treatments for cancer patients suffering from solid tumors such as pancreatic, ovarian and colorectal cancers, today announced that it will be presenting at the 9th annual LD Micro Main Event on Wednesday, December 7th at 1 PM PST / 4 PM EST at the Luxe Sunset Boulevard Hotel in Los Angeles, CA. James Nathanielsz, Propanc’s Chief Executive Officer, will be presenting, as well as meeting with investors.

The LD Micro Main Event is the largest independent conference for small/microcap companies and will feature 240 presenting names.

View Propanc Health Group Corporation’s profile here: http://www.ldmicro.com/profile/PPCH

News Compliments of Accesswire

To view the new Propanc video “Mechanism of Action” on anti-cancer product candidate, PRP, please click on the following link:

http://www.propanc.com/news-media/video

To be added to Propanc’s distribution list, please email PPCH@kcsa.com with ‘Propanc’ in the subject line.

About Propanc Health Group Corporation

Propanc is developing new cancer treatments for patients suffering from pancreatic, ovarian and colorectal cancers. We have developed a formulation of anti-cancer compounds, which exert a number of effects designed to control or prevent tumors from recurring and spreading throughout the body. Our products involve or employ pancreatic proenzymes, which are inactive precursors of enzymes. In the near term, we intend to target patients with limited remaining therapeutic options for the treatment of solid tumors. In future, we intend to develop our lead product to treat (i) early stage cancer and (ii) pre-cancerous diseases and (iii) as a preventative measure for patients at risk of developing cancer based on genetic screening. For more information, visit: www.propanc.com.

About LD Micro

LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. What started out as a newsletter highlighting unique companies has transformed into an event platform hosting several influential conferences annually (Invitational, Summit, and Main Event). In 2015, LDM launched the first pure microcap index (the LDMi) to exclusively provide intraday information on the entire sector. LD will continue to provide valuable tools for the benefit of everyone in the small and microcap universe. For those interested in attending, please contact David Scher at david@ldmicro.com or visit www.ldmicro.com/events for more information.

Contact:

Philip Carlson
KCSA Strategic Communications
PPCH@kcsa.com

SOURCE: Propanc Health Group Corporation via LD Micro

ReleaseID: 449943